Farther Finance Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

Farther Finance Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.76K	Buy	502 +380	+311%	+$4.73K	﹤0.01%	4839
2026 Q2	$1.27K	Buy	122 +72	+144%	+$653	﹤0.01%	5302
2026 Q1	$374	Buy	50 +30	+150%	+$341	﹤0.01%	5332
2025 Q4	$164	Buy	+20	New	+$230	﹤0.01%	5238
2025 Q3	–	Sell	-922	Closed	-$9.36K	–	5045
2025 Q2	$9.36K	Buy	+922	New	+$6.19K	﹤0.01%	3107

Other funds holding ORIC

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's ORIC Position: Q3 2026 in Review

Farther Finance Advisors increased its Oric Pharmaceuticals (ORIC) stake by 311% in Q3 2026, buying an estimated $4.73K and bringing the position to 502 shares worth $6.76K. The position accounts for ﹤0.01% of the portfolio, ranked #4839.

Farther Finance Advisors first reported a position in ORIC in Q2 2025 and has held it in 5 quarters since. The position peaked at $9.36K in Q2 2025. 3 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

Farther Finance Advisors held 502 shares of Oric Pharmaceuticals worth $6.76K as of Q3 2026.
Farther Finance Advisors bought 380 Oric Pharmaceuticals shares in Q3 2026, an estimated $4.73K.
Oric Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4839 holding.
Farther Finance Advisors first reported a position in Oric Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
Farther Finance Advisors's Oric Pharmaceuticals position peaked at $9.36K in Q2 2025.
3 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.